Can pharmacoeconomic guidelines be implemented successfully in Asia? (editorial) | NOVA. The University of Newcastle's Digital Repository

Home

Please use this identifier to cite or link to this item: http://hdl.handle.net/1959.13/43550

Title: Can pharmacoeconomic guidelines be implemented successfully in Asia? (editorial)
Author/Creator: Li, Shu Chuen
Institution: The University of Newcastle. Faculty of Health, School of Biomedical Sciences and Pharmacy
Description: Since the introduction of the first Australian pharmaceoconomic guidelines in 1993, for the pharmaceutical industry to use when preparing a submission for public reimbursement of new drugs, there has been a gradual and accelerating proliferation of pharmacoeconomic guidelines internationally. Viewing the situation in Asia, there is actually a much stronger rationale for introducing and applying pharmacoeconomic evaluation in drug reimbursement decisions. Many Asian countries share the same concerns about high pharmaceutical expenditures and overuse of medicine due to the nature and funding arrangements of the healthcare system.
Relation: Journal of Medical Economics Vol. 11, Issue 2, p. 341-343
Relation: http://informahealthcare.com/doi/abs/10.3111/13696990802221171
Date: 2008
Publisher: Informa Healthcare
Keyword(s): pharmacoeconomic guidelines; Asia; pharmaceutical industry; pharmaceutical expenditure; healthcare system
Resource Type: journal article
Identifier: http://hdl.handle.net/1959.13/43550
Identifier: ISSN:1369-6998

26 Visitors

30 Hits

NOVA. The University of Newcastle's Digital Repository